LAS VEGAS, Nov. 7, 2007 (PRIME NEWSWIRE) -- Cardio Infrared Technologies, Inc. (Pink Sheets:CIRT) announced today that Cardio Infrared Technologies, Inc. began clinical trials with Bucks County Clinical Research, Inc. (FDA Certified) and Dr. Richard M. Goldfarb, M.D., FACS. Bucks/Goldfarb will perform a Human Clinical Study on the "CardioCor(tm)" Exerbike equipment over a 12 week period. The study will be conducted on male and female patients who suffer from overweight and or excess cellulite and will position them in a full protocol of three 40-minute sessions for 12 weeks.
Documentation including before and after photographs, as well as statistically measured results will be provided at the conclusion of the study. After this time, a portion of the patients will be selected to continue in an ongoing clinical treatment program. Patients will also be monitored over the course of their sessions to garner other possible beneficial medicinal assessments from their sessions, including research into possible improvement from chronic back pain, arthritic conditions, autoimmune disorders, etc.
In response to this announcement, Wayne Bailey, President and CEO of CIRT commented, "Cardio-Infrared Technologies, Inc. is committed to factual analysis of the equipment and that it works as represented. The new clinical trials will provide the proof and support that is needed by the health and fitness industries. CIRT intends the study to confirm the current client testimonies of deep cleansing afforded by the combination of exercise and infrared benefits using the CardioCor(tm) Exerbike."
About Cardio Infrared Technologies, Inc.
Cardio Infrared Technologies, Inc is a technology and marketing company, which is focused on developing the revolutionary and evolutionary process of combining exercise equipment with medical benefits that go far beyond the normal benefits of standard exercise equipment. Cardio Infrared Technologies, Inc. is committed to continue to market this equipment to the exercise and medical markets and to aggressively expand the market to every country around the world. The equipment has already been featured on Good Morning America and The View. Cardio Infrared Technologies, Inc. also has an aggressive growth plan that includes acquisitions and development of innovate new equipment and programs in the exercise and medical industries.
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.The words or phrases "would be," "would allow," "intends to'" "will likely result," "are expected to," "will continue," "anticipate," "expect," "estimate," "project," "indicate," "could," "potentially," "should," "believe," "considers," or similar expressions are intended to identify "forward-looking statements." Actual results could differ materially from those projected in the forward-looking statements as a result of a number of risks and uncertainties. These include the company's historic lack of profitability, end user customer acceptance and actual demand, which may differ significantly from expectations, the need for the company to manage its growth, the need to raise funds for operations and other risks within the regulation of the industry. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation, to update any forward-looking statements to reflect occurrences, developments, events or circumstances after the date of such statement.